Neurizon Therapeutics LimitedASX: NUZ

Update - Proposed issue of securities - NUZ

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 9 pages · English

Summary by 6ix AI

Neurizon Therapeutics Limited has filed an update regarding a proposed issue of securities under a securities purchase plan. The maximum number of shares to be issued has been updated to reflect a potential oversubscription, allowing for a larger total than initially planned. The announcement also outlines the conditions and details of the offer, including the minimum and maximum acceptance values for investors. Proceeds from the proposed issue will be used for clinical and pre-clinical activities related to a specific trial.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Appendix 3B - Proposed issue of securities Update Summary Entity name NEURIZON THERAPEUTICS LIMITED Announcement Type Update to previous announcement Date of this announcement 16/11/2026 Reason for update to a previous announcement Maximum number of SPP Shares to be issued updated to 147,058,824....

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases